AlphaYouJA
Insider selling
Jonathan Allan sold $17K of Stoke Therapeutics, Inc. (STOK) stock
Jonathan Allan, General Counsel & Corp Sec of Stoke Therapeutics, Inc. (STOK), sold 627 shares of STOK stock worth $17K, per an SEC Form 4 filed Oct 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Oct 2, 2026.
- Traded
- Oct 2, 2026
- Disclosed
- Oct 2, 2026
- Filing delay
- 0 days
- Role
- General Counsel & Corp Sec
- Source
- SEC Form 4
More STOK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.